NCT02380976View on ClinicalTrials.gov

Phase 1 Clinical Trial of DW340 and DW330SR + DW1030 Co-administration in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2015

Conditions
Healthy
Interventions
DRUG

combination drug: DW330SR, DW1030

DRUG

DW340

Sponsors
All Listed Sponsors
lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY